CD274 and colorectal cancer: YKL-40 has been suggested to increase the expression of immune checkpoints (9, 42), and recently, a study found a positive correlation between the expression of YKL-40 in immune cells and PD-L1 expression in tissue sections from patients with colorectal cancer (43).